Affordable Access

Publisher Website

Novel Approaches to Therapy of Hypereosinophilic Syndromes

Authors
Journal
Immunology and Allergy Clinics of North America
0889-8561
Publisher
Elsevier
Publication Date
Volume
27
Issue
3
Identifiers
DOI: 10.1016/j.iac.2007.07.003
Disciplines
  • Biology
  • Medicine
  • Pharmacology

Abstract

There has been recent progress in the understanding of the pathogenesis of the hypereosinophilic syndromes (HES). This led to the distinction of subgroups, in which the underlying cause has been identified. Consequently, new treatment options became available, such as imatinib and mepolizumab, which proved to be promising. This article summarizes these new pharmacologic approaches to the therapy of HES.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments